+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Management of infantile parotid gland hemangiomas: a 40-year experience

Management of infantile parotid gland hemangiomas: a 40-year experience

Plastic and Reconstructive Surgery 125(1): 265-273

Infantile hemangiomas represent one of the most common childhood tumors. The authors have previously demonstrated that the most appropriate management for such tumors is a nonoperative approach. Some authors have recently advocated surgical management as the primary treatment. Medical treatment such as steroids or interferon therapy has also been proposed. Definitive treatment for infantile parotid gland hemangioma remains controversial. In the retrospective study portion of this article, the authors reviewed the last 400 charts of children with hemangiomas managed at the Montreal Children's Hospital over the past 40 years. Twenty patients with parotid hemangiomas were identified. In the literature review portion, the Ovid MEDLINE and PubMed databases were used to retrieve all published original articles on the management of parotid hemangiomas from 1950 to December of 2008. All of the authors' patients underwent successful nonoperative management, with 100 percent resolution of their parotid hemangiomas within 2 years of diagnosis, with an average follow-up time of 8.6 +/- 5.7 years. There were no complications of any of the treatments. The literature review retrieved a total of 413 patients in 12 original articles and four case reports. Management included observation and medical (steroid or interferon) and/or surgical treatment. Complications included failure to thrive, scarring, facial nerve palsy, and death. The authors have shown that nonoperative therapy resulted in regression and involution of infantile parotid hemangiomas with no major complications.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054242950

Download citation: RISBibTeXText

PMID: 19910858

DOI: 10.1097/prs.0b013e3181c2a55a

Related references

Intralesional Pingyangmycin therapy for 51 infantile patients with parotid gland hemangiomas. Shanghai Kou Qiang Yi Xue 18(2): 142-146, 2009

Management of hemangiomas of the parotid gland in children. Otolaryngologia Polska 39(2): 98, 1985

Infantile hemangiomas: a 7-year experience of a single-center. Clujul Medical 90(4): 396-400, 2017

Pathology and management of masses in the accessory parotid gland region: 24-year experience at a single institution. Journal of Cranio-Maxillo-Facial Surgery 46(2): 183-189, 2018

Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy. European Archives of Oto-Rhino-Laryngology 261(3): 143-146, 2004

Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience. Acta Paediatrica 101(10): E469-E474, 2012

Effect of propranolol on the treatment of infantile hemangiomas: a single tertiary center 3-year experience. Journal of Dermatological Treatment 25(5): 391-395, 2014

Does the pulsed tunable dye laser have a role in the management of infantile hemangiomas? Observations based on 3 years' experience. Plastic and Reconstructive Surgery 95(2): 305-312, 1995

Oral propranolol for parotid infantile hemangiomas. Journal of Craniofacial Surgery 26(2): 438-440, 2015

Endoscopic-assisted gland preserving therapy for the management of parotid gland sialolithiasis: Our preliminary experience. Journal of Cranio-Maxillo-Facial Surgery 43(8): 1650-1654, 2015

Discussion on: Oral Propranolol for Parotid Infantile Hemangiomas. Journal of Craniofacial Surgery 2017:, 2017

Role of imaging in the diagnosis of parotid infantile hemangiomas. International Journal of Pediatric Otorhinolaryngology 102: 61-66, 2017

Parotid gland tumours: a 15-year experience. Journal of the Royal College of Surgeons of Edinburgh 37(2): 89-93, 1992

Combination of propranolol and sclerotherapy for treatment of infantile parotid hemangiomas. International Journal of Clinical and Experimental Medicine 8(7): 10865-10874, 2015

Bleomycin A5 plus dexamethasone for control of growth in infantile parotid hemangiomas. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 108(1): 62-69, 2009